Story

Selectquote Stock Plummets After Missing Earnings, Issuing Weak Guidance

ENTHMSVIIDZHZH-TWJAKOHI
Aug 25, 20261 min read
Selectquote Stock Plummets After Missing Earnings, Issuing Weak Guidance
Text size
Background

Shares of Selectquote (SLQT) plunged in pre-market trading after the company announced fiscal fourth-quarter 2026 financial results that fell short of analyst expectations and issued a disappointing forecast for the upcoming fiscal year, signaling potential headwinds for its growth trajectory.

Disappointing Quarterly Results

Selectquote reported a double miss for the quarter ending in its latest release. The results failed to meet market consensus on both key metrics:

  • Loss Per Share: The company posted a loss of $0.19 per share, wider than the consensus estimate of a $0.15 loss per share.
  • Revenue: Quarterly revenue came in at $321.7 million, missing the anticipated figure of approximately $345.3 million.

Weak Forward Guidance Drives Sell-Off

The most significant factor impacting the stock was the company's forward-looking guidance. For fiscal year 2027, Selectquote projects revenue to be in the range of $1.35 billion to $1.45 billion.

Sample IUX Markets – In-articleAd

This forecast is approximately $200 million below the analyst consensus of $1.65 billion, raising significant concerns among investors about the company's near-term growth prospects. In response to the report, the stock fell 16.59% to $0.643 in pre-open trading.

Industry and Company Headwinds

The poor results and outlook follow a period of softening analyst sentiment, including a ratings downgrade from Weiss Ratings in mid-August and a cut from "strong-buy" to "hold" by Zacks in July. The company has previously pointed to structural challenges, including a major Medicare Advantage carrier reducing marketing spend and persistent reimbursement pressures from pharmacy benefit managers.

These issues are not unique to Selectquote, as peers in the insurance brokerage space face a similarly challenged environment related to Medicare Advantage reimbursement dynamics, which continue to pressure margins across the sector.

Read next

More on Stocks
Back to latest news

LATEST